| | 1432597-26-6 Basic information More.. |
| Product Name: | LDN212854 | | Synonyms: | LDN212854;Quinoline, 5-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-;BMP Inhibitor III;5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyriMidin-3-yl]quinoline;CS-1202;BMP INHIBITOR III;LDN212854;LDN 212854;5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline LDN 212854;LDN 212854 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | | CAS: | 1432597-26-6 | | MF: | C25H22N6 | | MW: | 406.48 | | EINECS: | 808-898-3 | | Mol File: | 1432597-26-6.mol |  |
Use
LDN-212854 (6 mg/kg, i.p.) effectively neutralize ALK2 signaling in vivo, and potently inhibits heterotopic ossification in an inducible transgenic mutant ALK2 mouse model of fibrodysplasia ossificans progressiva.
- LDN-212854
-
- US $98.00-326.00 / mg
- 2026-04-22
- CAS:1432597-26-6
- Min. Order:
- Purity: 98.00%
- Supply Ability: 10g
- LDN212854
-
- US $1.00 / KG
- 2019-12-23
- CAS:1432597-26-6
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
|
|
1432597-26-6
Recommend Suppliers |
|